> Ebola is a scary disease yet rare (across the entire planet) so there doesn't seem to be a lot of monetary reason to invest in it. Antibiotic resistance is fa

> Ebola is a scary disease yet rare (across the entire planet) so there doesn't seem to be a lot of monetary reason to invest in it. Antibiotic resistance is far more widespread. All true, but once one understands the microbiology, it becomes obvious why drug companies are giving up on antibiotics. It's perfectly rational behavior -- no matter what antibiotics we invent, the microbes will evolve resistance to them in a short time. That's been the history of antibiotics until now, and there's no reason to expect the future to be any different -- if anything, it will probably become worse. http://www.pbs.org/wgbh/pages/frontline/health-science-technology/hunting-the-nightmare-bacteria/dr-arjun-srinivasan-weve-reached-the-end-of-antibiotics-period/ http://www.pbs.org/wgbh/pages/frontline/health-science-techn... Title: "Dr. Arjun Srinivasan: We’ve Reached 'The End of Antibiotics, Period'"